Skip to main content

BioTech

A Drug Being Developed to Treat Anxiety and Cognitive Decline in the Elderly

Published

Aug 9, 2023

Erez Aminov, CEO of MIRA Pharmaceuticals, and Dr. Adam Kaplin, Co-Founder and Chief Science Officer of MIRA Pharmaceuticals, join Jill Malandrino on Nasdaq TradeTalks to discuss a drug being developed to treat anxiety and cognitive decline in the elderly and chronic pain without impurities or the negative side effects associated with cannabis plant extracts.

No transcript available

More in this Series

See all

My Quotes
My European Quotes
Watchlist
Portfolio

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.

/

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.

/

Edit Watchlist

Your Watchlist is empty.

Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.

/

Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Go to Smart Portfolio